Avanafil
Stendra, Spedra (avanafil) is a small molecule pharmaceutical. Avanafil was first approved as Stendra on 2012-04-27. It is used to treat erectile dysfunction in the USA. It has been approved in Europe to treat erectile dysfunction. Stendra's patents are valid until 2025-04-27 (FDA).
| Trade Name | Spedra |
|---|---|
| Common Name | Avanafil |
| Indication | erectile dysfunction |
| Drug Class | Pde5 inhibitors |
